MariMed (OTC:MRMD – Get Free Report) was upgraded by investment analysts at Ventum Cap Mkts to a “strong-buy” rating in a research report issued to clients and investors on Thursday, Zacks.com reports.
MariMed Stock Performance
MRMD stock remained flat at $0.18 on Thursday. The company had a trading volume of 220,343 shares.
About MariMed
Featured Articles
- Five stocks we like better than MariMed
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Why Wall Street Analysts Raised Price Targets for Suncor Stock
- Earnings Per Share Calculator: How to Calculate EPS
- Is Super Micro Computer a Buy After Shares Sink 20% on Earnings?
- What to Know About Investing in Penny Stocks
- Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.